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Abstract 
 
Purpose: Irritable Bowel Syndrome (IBS) is a functional gastrointestinal 
disorder characterised by abdominal pain and altered bowel habits. It is 
estimated to affect 10-22% of the UK population. The use of psychological 
interventions in IBS is increasingly empirically supported, but little is known 
about the mechanism of psychological treatment approaches. The present 
systematic review aimed to investigate the mechanisms of psychological 
treatment approaches applied to IBS. 
 
Methods: The systematic review included studies conducting mediation analysis 
in the context of psychological interventions for IBS, focusing on the outcomes of 
symptom severity and/or quality of life (QoL).  
 
Results: Nine studies in total were included in the review. Eight of the studies 
assessed mediation in the context of cognitive behavioural-based interventions 
and one study assessed mediation in a mindfulness based stress reduction 
intervention. Results indicate that change in illness specific cognitions are a key 
process by which psychological treatments may have an effect on the outcomes 
of symptom severity and QoL. Furthermore, results suggest that while 
gastrointestinal specific anxiety may also be a key mechanism of treatment 
effect, it would appear that general or state anxiety is not. Although less 
commonly included in mediation analysis, illness specific behaviours may also 
have a mediating role.  
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Conclusions: A mediational model amalgamating the results of studies is 
proposed to illustrate the findings of the review. The model depicts the process 
by which psychotherapy, changes illness specific cognitions, behaviours and 
anxiety to achieve reduction in symptom severity.  
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ANS – Autonomic Nervous System  
BGA – Brain-Gut-Axis  
BSSS – Bowel Symptom Severity Scale  
CBT – Cognitive Behavioural Therapy 
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GSA – Gastrointestinal Specific Anxiety 
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MBSR – Mindfulness Based Stress Reduction  
PIT – Psychodynamic Interpersonal Therapy 
QA – Quality Assessment  
QoL – Quality of Life 
RCT – Randomised Control Trial  
SEM – Structural Equation Modelling 
VSI – Visceral Sensitivity Index 
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Background  
Irritable Bowel Syndrome: Definition, Aetiology and Prevalence  
 
Irritable bowel syndrome (IBS) is a chronic disorder that usually involves 
periods of remittance in between flare-ups that may vary in severity. The 
diagnosis of IBS is based on the absence of any other physiological markers that 
explain the experience of symptoms. For this reason many people with a 
diagnosis of IBS may have undergone several investigative procedures prior to 
diagnosis. The prevalence of IBS in the general population is estimated to be 
10.5% (Wilson et al., 2004). This varies across ages and gender, with women 
aged between thirty and thirty nine being twice as likely to experience it than 
men of the same age range (Dalrymple and Bullock, 2008). IBS is associated with 
impaired quality of life (QoL) and distress (Athanasakos and Emmanuel, 2013, 
Wu, 2012) as well as high rates of co-morbidity of anxiety (Fond et al., 2014). 
 
The ROME criteria were developed to classify functional gastrointestinal 
disorders (FGIDs) that were not otherwise explained by structural or tissue 
abnormalities. The most recent ROME IV criteria asserts that the prevalent 
symptom of IBS is abdominal pain, which must be associated with changes in 
bowel movements or stool consistency (Drossman, 2016). The criteria identify 
four bowel subtypes: constipation predominant (IBS-C), diarrhoea predominant 
(IBS-D), alternating bowel pattern (IBS-A) and unclassified (IBS-U). These 
subtypes are categorised based on the proportion of symptomatic stools that are 
loose/watery or hard/lumpy.  
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Brain-Gut Axis 
Although the cause of IBS remains unclear, increasing credence is given to the 
Biopsychosocial aetiological model of IBS (Engel, 1981). This proposes that 
symptoms occur due to an interaction between biological, psychological and 
social mechanisms (Mayer et al., 2015, Quinton and Keefer, 2014, Van 
Oudenhove et al., 2016). A physiological system by which this interaction may 
occur is referred to as the “brain-gut axis” (BGA) (Jones et al., 2006). The BGA is a 
bidirectional communication between the enteric nervous system (ENS) located 
in the walls of the gastrointestinal tract, and the autonomic and central nervous 
systems (Fichna and Storr, 2012). The mechanism of communication involves 
the autonomic stress response and the endocrine, neuroimmune and neural 
pathways (Wu, 2012) utilizing the hypothalamic – pituitary- adrenal axis (HPA 
Axis).  A recent review comprehensively explains how the BGA underpins the 
psychological, social and physiological interactions to contribute to the 
experience of symptoms in functional bowel disorders (Van Oudenhove et al., 
2016). The BGA is therefore the proposed physiological mechanism by which 
psychological factors can exert effect on physical outcomes such as symptom 
severity (Van Tilburg et al., 2013). 
 
Psychological Treatments in IBS 
 
It is well established that psychological factors affect both quality of life (QoL) 
and symptom severity in IBS (Van Tilburg et al., 2013) and psychological 
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treatments have been developed over the years to target such factors.  Meta-
analyses and systematic reviews have established the efficacy of psychological 
treatments in reducing symptom severity in IBS (Ford et al., 2009, Kennedy et al., 
2012, Lackner et al., 2004, Li et al., 2014). The most commonly utilized 
psychological treatments in IBS are considered below in terms of the underlying 
theoretical model, mechanisms and empirical support.  
 
Cognitive Behavioural Therapy (CBT) 
 
To date the majority of psychological interventions conducted in IBS are CBT-
based, with strong empirical support demonstrating its efficacy in reducing 
symptom severity and enhancing QoL/impact on life (Ford et al., 2014, Ford et 
al., 2009, Li et al., 2014). This being said, there is not one agreed CBT protocol for 
IBS and different studies use different models and treatment techniques 
(Henrich et al., 2015).  
Some protocols may put more emphasis on targeting general or state anxiety, as 
opposed to gastrointestinal specific anxiety (GSA) (Blanchard et al., 2007, 
Lackner et al., 2007). Protocols focusing on GSA, tend to more heavily utilise 
exposure-based techniques (Craske et al., 2011, Hunt et al., 2009, Ljótsson et al., 
2010). It has also become common for CBT protocols to include mindfulness 
(Ljótsson et al., 2010, Wolitzky-Taylor et al., 2012). Other protocols follow a 
three systems model, specifically focusing on the change of illness related 
cognitions and behaviours (Kennedy et al., 2005, Kennedy et al., 2006b), as 
opposed to the targeting of  thoughts and behaviours more commonly related to 
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general anxiety.  Although there may be shared mechanisms of change across 
protocol approaches, the way in which treatment works may differ between 
studies depending on the model and interventions used.  
 
Hypnotherapy 
Hypnotherapy (HT) as applied to IBS is called “gut-directed” or “gut-focused” 
hypnotherapy. The process involves the use of hypnotic techniques that are 
designed to relax the automatic reaction to symptoms, and allows individuals 
more control in their cognitive and physical response to them (Gonsalkorale et 
al., 2004). Sessions consist of induction of a hypnotic state and hypnotic 
suggestions to reduce threat perception of symptoms. Evidence suggests that 
this approach is effective in improving both physical symptoms of IBS and 
enhancing QoL (Miller et al., 2015, Wilson et al., 2006). 
 
There has been substantial interest in the mechanisms of HT in IBS (Simrén, 
2006, Spiller et al., 2007, Tan et al., 2005). One of the key mechanisms 
consistently implicated in the literature seems to be the role of cognitions. One 
particular study found that after HT, IBS improvement was associated with a 
reduction in IBS-related cognitions (Gonsalkorale et al., 2004). The authors 
suggested that the hypnotherapeutic approach used could be regarded as a form 
of cognitive restructuring as it involved techniques to increase individuals’ 
perceived control over symptoms.  
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Psychodynamic Psychotherapy 
Psychodynamic psychotherapy for IBS aims to reduce symptoms through 
enhancing interpersonal relationships, which are purported to be the underlying 
source of symptomatic complaints (Guthrie, 2002). This approach is called 
“Psychodynamic-Interpersonal therapy” (PIT). Sessions are designed to provide 
individuals with insight into the link between interpersonal difficulties and 
symptoms, and between emotions and bowel symptoms. A limited number of 
studies have assessed the efficacy of PIT for IBS with some support for its 
efficacy in reducing symptom severity (Svedlund et al., 1983, Creed et al., 2003, 
Guthrie et al., 1991). 
 
There is not an established model by which PIT is proposed to improve IBS 
symptoms, however Hyphantis et al (2009) hypothesized that PIT would lead to 
a reduction in IBS symptoms, by reducing psychological distress associated with 
interpersonal conflict. This paper assessed the mediating effect of psychological 
distress on interpersonal distress, finding significant mediation. It did not 
however assess the relationship between treatment, these processes and the 
outcome of symptom severity.  
 
Establishing mechanisms of psychological treatments for IBS 
The primary way to elucidate mechanistic processes in psychological research is 
by conducting mediation analysis (Baron and Kenny, 1986, MacKinnon., 2008, 
Windgassen et al., 2015). This allows potential mechanistic variables to be 
assessed in the context of the proposed pathway between treatment and 
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outcome (Kazdin, 2007). A simplistic model of mediation is illustrated in figure 1. 
This demonstrates how a treatment may cause change in an outcome, by first 
eliciting change in a mediating variable. An early approach to conducting 
mediation analysis was proposed by Baron & Kenny (Baron and Kenny, 1986), 
utilsing a series of regressions. Mediation is said to occur where I is shown to no 
longer influence (or have less of an influence on) O when M is controlled for. This 
approach is sometimes referred to as the “Causal Steps” approach to mediation 
(MacKinnon et al., 2002, Mackinnon et al., 2007).  
 
Structural Equation Modelling (SEM) is another statistical method to assess 
mediation. SEM is sometimes referred to as “path analysis” when it is conducted 
utilising observed variables (MacKinnon., 2008). SEM can also allow the 
modelling of relationships between variables utilising underlying latent traits 
and allows models to account for measurement error (Bollen and Pearl, 2013, 
MacKinnon., 2008). An advantage to the SEM/path analysis approach to 
mediation is that it can model multiple outcomes/regressions simultaneously, 
which allows for longitudinal modelling of multiple measures of mediators and 
outcomes. In practical terms, this means that the impact of numerous mediators 
identified by a theoretical model have their impact on outcome assessed 
simultaneously.  
 
Although the number of studies empirically investigating the efficacy of 
psychological therapies for IBS have increased, little is known about how 
psychological treatments work (Murphy et al., 2009).  Investigating the key 
processes involved in creating change in outcome, is important to identify 
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components of therapy that are necessary for achieving desired outcomes. It 
therefore also provides opportunity for treatment modification and 
enhancement. The present review aims to systematically assess psychological 
variables shown to significantly mediate treatment effect on the outcomes of 
symptom severity and QoL.  
 
Methodology 
The systematic review methods adhered to PRISMA guidelines to ensure the 
standardised reporting of systematic reviews (Moher et al., 2009).  
 
Literature Search 
The search was conducted using electronic databases Ovid, PsycInfo, Embase, 
MEDLINE, PsycArticles and Global Health.  The search was conducted three 
times in the months April 2014, June 2014, July 2015 and May 2016 
(Supplementary Appendix S1). One additional paper was identified by searching 
citations of the included papers.  
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Eligible Studies 
In accordance with the recommendations of the Centre for Reviews and 
Dissemination (Chambers et al., 2009), the search strategy was developed using 
a PICOS format. The acronym refers to (P) population (I) intervention (C) 
comparator group (O) the outcome or endpoint interested in (S) study design. 
This shaped the inclusion criteria (Supplementary Appendix S2).   
 
To be included studies had to have conducted mediation analysis on an 
intervention delivered prospectively. This was to ensure that mediation was 
designed to test mechanisms of efficacy for delivered interventions rather than 
to explore potential mechanisms of outcome in the absence of an intervention.  
 
Assessing Study Bias 
The Cochrane Handbook stipulates that systematic reviews should assess a risk 
of bias in included studies (Higgins and Green, 2008). Two separate tools were 
used. One was designed to assess the overall quality of randomized controlled 
trials (RCTs) using the original RCT publication and the other was developed to 
assess the quality of mediation analysis. The RCT quality assessment tool 
(Supplementary Appendix S3) used was   the Cochrane Guide for Quality 
Assessments (Van Tulder et al., 2003). Only two criteria were not included in the 
present review. These related to (a) blinding of the participants and (b) blinding 
of the care provider, which were not practical to use due to the nature of the 
interventions being studied.  Papers were rated as “yes”, “no” or “unclear” 
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against each criteria. Papers were scored out of a total of 9. Answers of “no” or 
“unclear” scored 0 and answers “yes” scored 1. This rating is adherent to the 
recommendations by Cochrane (Higgins and Green, 2008). The papers were 
rated by the first author and AS.  
 
Two approaches were used to develop the mediation quality assessment tool 
(Supplementary Appendix S4). Items were based on a previously developed tool 
(Lubans et al., 2008). Some items were altered to reflect the aims of the present 
review. Additional items were added to reflect the range in quality across the 
studies included in review and against standards stipulated in the mediation 
literature (MacKinnon., 2008).  
 
The additional items were (i) Was more than one model fit criteria reported 
where path models were used in analysis?  (ii) Was the mediator variable/s 
assessed for change? (iii) Was temporal precedence accounted for in the 
analysis? (iiii) Did the study report confidence intervals of the mediated effect? 
When the Baron & Kenny framework was used, it was stipulated that confidence 
intervals should be used for paths a and b. Where SEM or path analysis was used, 
confidence intervals for the indirect path/s were stipulated. 
 
The additional criteria are detailed in order of their listing (i) It is recommended 
that more than one model fit criteria should be used in SEM because each criteria 
are affected by different factors (such as sample size, model complexity and data 
normality) (Hair et al., 1992, McDonald and Ho, 2002) (ii) It was deemed 
important to establish whether the mediator was assessed for change, to 
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ascertain whether the interventions were effective in producing change in 
proposed mediating variables. (iii) Studies were rated on the inclusion of design 
accommodating temporal precedence as this is an important design 
consideration to allow inferences regarding causality. (iiii) Confidence intervals 
were deemed necessary to indicate the magnitude of the path coefficient.  
 
Papers using Baron & Kenny’s Causal Steps approach were scored out of 7, 
whilst other approaches to measuring mediation were scored out of 8. This was 
because the item regarding assessment of fit criteria was not relevant to the 
causal steps approach to mediation. 
 
Quality assessment (QA) for mediation was conducted by two of the authors, the 
first author and the fourth author. The third author was used to rate the quality 
of one paper to minimize the risk of bias as the fourth author was also an author 
of this paper. Any disparities were discussed with all raters during quality 
assessment, enabling full agreement on criteria.  
 
Results 
Three hundred and thirty seven search results were returned in the initial 
search. 317 were excluded after screening titles and abstracts, and removing 
duplicates (figure 2). The full text of twenty articles were screened and nine 
were left to review (Chilcot and Moss-Morris, 2013, Garland et al., 2012, Hunt et 
al., 2009, Jones et al., 2011, Labus et al., 2013, Lackner et al., 2007, Ljótsson et al., 
2013, Reme et al., 2011, Wolitzky-Taylor et al., 2012). The most common reasons 
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for exclusion at the full-text screening phase were studies not performing 
mediation analysis or not conducting an intervention (Fig 2).  Two studies that 
conducted mediation were excluded as they either did not assess mediation of 
treatment effect on the outcome of symptom severity or QoL (Hyphantis et al., 
2009) or they conducted mediation in the absence of an intervention cross-
sectionally (Rutter and Rutter, 2002) 
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Study Characteristics  
All of the studies included were RCTs.  Control groups included wait list control 
(WL) (Hunt et al., 2009, Labus et al., 2013, Lackner et al., 2007), treatment as 
usual (TAU) (Chilcot and Moss-Morris, 2013, Jones et al., 2011), provision of 
medication (Reme et al., 2011) and alternative psychological or psycho-
education interventions (Garland et al., 2012, Jones et al., 2011, Lackner et al., 
2007, Ljótsson et al., 2013, Wolitzky-Taylor et al., 2012), Three studies compared 
the active treatment with two control groups (Jones et al., 2011, Lackner et al., 
2007, Wolitzky-Taylor et al., 2012) and the rest utilised a single control group.  
Participants were recruited from primary care (Chilcot and Moss-Morris, 2013, 
Reme et al., 2011), secondary care alone (Labus et al., 2013), a mixture of 
secondary care and wider community advertising (Garland et al., 2012, Jones et 
al., 2011, Lackner et al., 2007, Ljótsson et al., 2013, Wolitzky-Taylor et al., 2012) 
and from online IBS support resources (Hunt et al., 2009). Sample sizes ranged 
from 54 to 195 (median =76). The follow up periods for assessing outcome 
measures ranged from three months to 12 months. The range of follow up 
periods for outcomes included in the mediation analysis was six weeks to eight 
months, with only one study including outcomes up to 8 months in the mediation 
analysis (Chilcot and Moss-Morris, 2013).  A summary of the study 
characteristics is presented in table 1. 
 
Quality Assessment 
RCT Quality Assessment 
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Studies ranged in quality from 4/12 (Hunt et al., 2009, Labus et al., 2013) to 9/12 
(Chilcot and Moss-Morris, 2013, Garland et al., 2012). The majority of studies 
were found to be of moderate quality fulfilling 7/12 or above. (Supplementary 
Appendix S3).  
 
Mediation Quality Assessment 
Three studies met 7/8 or 6/7 of the QA items (Chilcot and Moss-Morris, 2013, 
Ljótsson et al., 2013, Wolitzky-Taylor et al., 2012). The majority of the rest were 
of moderate quality fulfilling 4 to 5/8 of the criteria (Hunt et al., 2009, Lackner et 
al., 2007) (Supplementary Appendix S4). 
 
Population Characteristics 
The mean age of participants in each study ranged from 33 to 48. A greater 
proportion of participants were women (72.5 % or greater) as is generally found 
in IBS populations (Dalrymple and Bullock, 2008). One study chose to recruit 
only female participants (Garland et al., 2012), with the reasons for this not 
explained. Classification into types of IBS differed across studies. Only one study 
used the ROME I (Jones et al., 2011) or III criteria (Ljótsson et al., 2013). The 
majority of recruited participants conformed to ROME II criteria (Chilcot and 
Moss-Morris, 2013, Garland et al., 2012, Labus et al., 2013, Lackner et al., 2007, 
Wolitzky-Taylor et al., 2012). One study relied on GP diagnosis of IBS (Reme et 
al., 2011) and another on self-reported IBS (Hunt et al., 2009). 
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The measures of illness severity included the Irritable Bowel Syndrome Severity 
Scoring System (IBS-SSS) (Francis et al., 1997), the Gastrointestinal Symptom 
Rating Scale modified for IBS (GSRS – IBS) (Wiklund et al., 2009), the Bowel 
Symptom Severity Scale (BSSS) (Boyce et al., 2000), a composite BSSS measure 
(Wolitzky-Taylor et al., 2012), a global gastrointestinal rating using a 20 point 
rating scale (Labus et al., 2013) and a physician rated severity score ranging 
from symptoms absent to very severe symptoms (Lackner et al., 2007). Samples 
consisted of participants suffering with moderate to severe symptoms. One study 
did not use classifications of mild to severe symptom severity, but instead 
provided means out of a total possible score of 40 for frequency, distress and 
interference of symptoms (Jones et al., 2011). 
Therapy Models & Interventions 
Nine of the studies assessed mediation in the context of cognitive behaviourally 
based interventions. Protocols varied across studies as reflected in table 3. One 
study conducted mindfulness based stress reduction (MBSR) tailored to IBS 
symptoms (Garland et al., 2012). The method of intervention delivery, duration 
of sessions and period of interventions are summarised in Table 1.  
Hypothesized Pathways 
The hypothesized pathways of change are illustrated in figure 3. It is important 
for mediation analysis to be conducted according to a hypothesized model rather 
than as an exploratory exercise (Johansson and Høglend, 2007). Accordingly, it 
would be expected that studies would assess models of mediation to match the 
stated hypothesized pathways. One paper presented two contrasting 
hypothesized pathways (represented by a and c in Figure 3) (Lackner et al., 
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2007). However the final model that was evaluated includes additional paths 
incorporating QoL. This appears to be exploratory modelling aiming to achieve 
the second aim of the paper, which was stated as “to examine the 
interrelationships among symptom improvement, QoL and distress”. Another 
paper did not state a directional hypothesis regarding which variables were 
likely to mediate treatment effect but rather hypothesized that numerous 
variables may do so without a pre-specified mediation model (Labus et al., 
2013). 
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Figure 3: Hypothesized mediated pathways; The diagrams illustrate the hypothesized mediation pathways across 
papers included in review. The letters indicate which hypothesized pathways were identified in which papers. A. 
(Jones et al., 2011, Lackner et al., 2007) B. (Lackner et al., 2007) C. (Hunt et al., 2009, Ljótsson et al., 2013, 
Wolitzky-Taylor et al., 2012)E. (Labus et al., 2013) F. (Garland et al., 2012) a= (Jones et al., 2011) b = (Hunt et al., 
2009) c= Reme et al (Reme et al., 2011) included gastrointestinal specific behaviours and Chilcot & Moss-Morris 
(Chilcot and Moss-Morris, 2013) included general unhelpful behaviours 
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Mediators 
Results of analyses are grouped by the specific mediator variables entered into 
the models.  
Mediators of treatment effect on symptom severity outcome 
 
Perceived Stress 
One study assessed perceived stress as a mediator of treatment effect (Labus et 
al., 2013). This was not a significant mediator.  
Cognitions & Metacognitions  
Four studies investigated whether both cognitions and general 
anxiety/psychological distress mediated the treatment effect (Chilcot and Moss-
Morris, 2013, Garland et al., 2012, Hunt et al., 2009, Labus et al., 2013). Of these, 
three found that cognitions rather than anxiety mediated the treatment effect 
(Chilcot and Moss-Morris, 2013, Garland et al., 2012, Hunt et al., 2009), while one 
did not (Labus et al., 2013). Of these studies, one study assessed all mediators 
simultaneously (Garland et al., 2012) and three conducted mediation analyses 
for each mediator separately (Labus et al., 2013, Chilcot and Moss-Morris, 2013, 
Hunt et al., 2009).  
 
In addition, one study assessed cognitions as a mediator of treatment effect 
without a measure of anxiety/psychological distress. This found that cognitions 
significantly mediated symptom severity along with behaviours (discussed 
below)(Reme et al., 2011).  
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The types of cognitions that mediated treatment effects included negative 
illness-specific beliefs (Chilcot and Moss-Morris, 2013, Reme et al., 2011), pain-
specific catastrophizing (Garland et al., 2012) and general catastrophizing (Hunt 
et al., 2009) (table 2). The illness-specific beliefs measure used by Chilcot & 
Moss-Morris (Chilcot and Moss-Morris, 2013) was the Brief Illness Perception 
Questionnaire tailored to IBS. This measured beliefs about the chronicity, 
seriousness, and controllability of IBS symptoms.  The Cognitive Scale for 
Functional Bowel Disorders (CSFBD), used by Reme et al (Reme et al., 2011) 
measured the degree of unhelpful beliefs about IBS, with specific items about 
interpretations of bowel symptoms and reactions to them. Metacognitions were 
also found to be significant mediators of treatment effect (Garland et al., 2012). 
These included non-reactivity and reinterpretation of pain.  
 
General Anxiety or Psychological Distress  
Of the three studies that investigated the mediating role of anxiety, one found a 
significant mediated effect in participants who had low baseline QoL (Labus et 
al., 2013) and one did not find a significant mediated effect of anxiety (Jones et 
al., 2011). The third did not report confidence intervals, effect sizes or 
significance levels of the path containing distress as a mediator (Lackner et al., 
2007) (Table 2). The extent to which the model fit the data was also not reported 
in this paper.  
 
Jones et al., (Jones et al., 2011) tested whether both anxiety and depression had a 
mediating role in a path model that included a feedback loop from anxiety and 
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depression to symptom severity, and a direct path from treatment to symptom 
severity. The model was not found to fit the data adequately and individual 
confidence intervals, effect sizes or significance levels were not reported for 
individual mediation paths for either variable. Labus et al (Labus et al., 2013) 
also investigated the mediating role of depression but found no significant 
mediation.  
Gastrointestinal Specific Anxiety (GSA)  
Two studies assessed the GSA utilising the Visceral Sensitivity Index (VSI) (Labus 
et al., 2004) individually as a mediator of treatment effects (Ljótsson et al., 2013, 
Wolitzky-Taylor et al., 2012) both finding significant mediation. One found that 
reduction in GSA mediated treatment effect for the intervention group but this 
did not differentiate from the two comparative control groups (Wolitzky-Taylor 
et al., 2012).  
In the three other studies in which GSA was included as a mediator along with 
other variables, one found it to be a significant mediator along with other 
cognitive and metacognitive measures (Garland et al., 2012). One study used an 
alternative measure to the VSI and did not find significant mediation of GSA 
(Hunt et al., 2009). It did however conclude that there was marginal mediation 
with indirect effects yeilding a significance of p=.09 . The third study did not find 
GSA to be a significant mediator (Labus et al., 2013) . 
 
Behaviours  
Behavioural responses were assessed as mediators in two CBT-IS studies, one 
assessing CBT delivered face-to-face (Reme et al., 2011, Chilcot and Moss-Morris, 
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2013) and one evaluating a self-management CBT intervention with some 
minimal face-to-face and telephone therapist contact (Chilcot and Moss-Morris, 
2013). The former measured behaviours specific to IBS such as checking stools 
for abnormalities and avoidance of social events due to bowel symptoms (Reme 
et al., 2010). The latter measured all-or-nothing and resting/avoidance 
behaviours related generally to illness but not specifically IBS. These were not 
found to mediate treatment effect, whereas behaviours specific to IBS did 
significantly mediate. IBS specific behaviour was found to be a significant 
mediator in a path following this sequence: treatment  behaviours  
cognitions  symptom severity. This model was found to fit the data better than 
a change in cognitions preceding a change in behaviour. It must however be 
noted, that the analysis lacked temporal precedence limiting the inferences 
about order of causality of these mediators. The authors stated that mediation 
was conducted utilising two time points instead of three, as there was no further 
change at the third time point.  
 
QoL 
One study found this to significantly mediate treatment effect for participants 
with low baseline QoL, but not for those with medium to high baseline QoL 
(Labus et al., 2013).  
 
Mediators of treatment effect on QoL outcome 
Five of the studies (Chilcot and Moss-Morris, 2013, Garland et al., 2012, Hunt et 
al., 2009, Lackner et al., 2007, Reme et al., 2011) assessed mediation of treatment 
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effects on QoL outcomes, including impaired functioning as measured by the 
Work and Social Adjustment Scale (Mundt et al., 2002). Change in IBS specific 
cognitions appeared to mediate change in outcome, with three of four studies 
assessing cognitions as a mediator of treatment on QoL finding significant 
mediation (Chilcot and Moss-Morris, 2013, Garland et al., 2012, Reme et al., 
2011) (table 2).  One study found no mediation through anxiety or general and 
IBS-specific catastrophizing cognitions (Hunt et al., 2009) and another found that 
reduction in symptom severity mediated improvement in QoL (Lackner et al., 
2007). The latter model found significant paths from CBT   symptom severity 
 QoL  distress QoL.  
Discussion 
Summary of results 
The review assessed which psychological variables significantly mediated 
treatment effects on the outcome of symptom severity and/QoL. Eight studies 
assessed mediation in the context of CBT interventions. The results indicate that 
both GI specific cognitive change and GSA are key mechanisms by which 
psychological treatments have effect on both symptom severity and QoL. Four 
out of five studies assessing cognitions as a mediator found them to mediate the 
effects of treatment on symptom severity. Three out of five studies assessing GSA 
as a mediator found significant mediation, and one found a trend towards 
significant mediation. Of the three studies that assessed general 
anxiety/psychological distress, only one found it to significantly mediate 
treatment effect (Labus et al., 2013). This study found evidence of moderated 
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mediation, in that anxiety was only found to significantly mediate treatment in 
participants who had low baseline QoL. The stratification of analysis by QoL does 
unfortunately reduce the power to detect significant mediators and makes 
results hard to interpret.  
 
Only two studies assessed behavioural responses as a mediator (Reme et al., 
2011, Chilcot and Moss-Morris, 2013); one measuring IBS specific behaviours, 
found it to be a significant mediator (Reme et al., 2011) and the other, measuring  
more general all-or-nothing (boom or bust) and avoidance behaviour, did not 
(Chilcot and Moss-Morris, 2013).  
 
Similarly, the trend for mediation of treatment effects on QoL found that changes 
in cognitions resulted in improved QoL (Reme et al., 2011, Chilcot and Moss-
Morris, 2013). Two studies assessed the mediating effect of psychological 
distress and cognitive factors on QoL. Of these one found no mediation (Hunt et 
al., 2009) and the other found that a decrease in GSA and pain catastrophizing 
resulted in an enhanced QoL (Garland et al., 2012). Lackner et al (2007) found a 
series of significant paths demonstrating that CBT had direct effects on symptom 
severity and that this influenced QoL (table 2). However, the fit of this path 
model to the data was not reported and therefore the results should be 
interpreted with caution.  
 
Quality of Studies  
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Most studies were classified as moderate to high quality in the RCT QA. The two 
criteria that were most commonly not met were whether the outcome assessor 
was blinded and whether compliance was described and acceptable. Often it was 
unclear as to whether the outcome assessor was blind or not, or what the 
process for collecting outcomes was. In terms of the compliance of participants 
to the interventions, this was often not described and where it was, it was low. In 
one study around 40% of participants were considered not to have completed a 
full course of therapy (Kennedy et al., 2005, Reme et al., 2011). 
 
Quality as assessed specifically for the mediation analyses was also generally 
moderate across the studies. All studies included a control group in the analysis 
and all studies were designed to influence mediating variables as determined by 
the inclusion criteria. Around half of the studies failed to account for temporal 
ordering of mediator change prior to outcome change in the analysis by using 
variables measured at the same time point (Jones et al., 2011, Garland et al., 
2012, Hunt et al., 2009, Lackner et al., 2007, Reme et al., 2011). This means that 
the extent to which causal interpretations can be made is limited. Four studies 
out of seven that used path analysis or SEM did not make clear whether they 
used more than one assessment of model fit (Chilcot and Moss-Morris, 2013, 
Jones et al., 2011, Labus et al., 2013, Lackner et al., 2007). Not reporting a range 
of model fit indices, reduces transparency as to whether the model fits the data 
taking into account different factors such as sample size and model complexity.  
 
Five out of the nine studies did not present confidence intervals for the indirect 
paths (Garland et al., 2012, Hunt et al., 2009, Jones et al., 2011, Lackner et al., 
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2007, Wolitzky-Taylor et al., 2012). Neglecting to report confidence intervals in 
any study employing statistical methods renders it uninterpretable; in these 
cases it prevents us from gaining insight into the likely values of the mediated 
effect. Furthermore, a subset of these studies conducted path analysis but did not 
report path coefficients for the indirect effect (Jones et al., 2011, Lackner et al., 
2007). Consequently interpretations of the size or extent of the mediated effect 
cannot be made without doing further calculations.  
 
 
Issues with Analysis Comparisons 
A predominant limitation of the use of the Baron & Kenny framework utilizing a 
series of regressions, is that it has low statistical power as compared to SEM or 
path analysis (Hayes, 2009, MacKinnon et al., 2002, MacKinnon., 2008, 
Windgassen et al., 2015). It also does not allow for investigation of more complex 
mediation modeling investigating whether one mediator precedes another or 
works simultaneously. Different approaches to mediation analysis make study 
comparison challenging, as some analyses provide more comprehensive 
assessment of mediation than others.  
 
Another issue complicating the comparison of mediation studies is the inclusion 
or non-inclusion of covariates. Some analyses control for covariates such as 
baseline measures of the outcome, mediator variable or both. Inclusion of 
covariates is recommended in order to reduce bias in mediation effect estimates, 
and leads to a greater understanding of the influence of potential confounding 
variables (MacKinnon and Pirlott, 2015, Mackinnon et al., 2007, VanderWeele, 
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2015). Less than half of the papers included in the review included covariates in 
the analysis. It is generally straightforward to adjust for baseline measures of 
mediators and outcome, which may be amongst the most important confounders 
of the mediator/outcome relationship. 
 
The Role of Theory 
The design of intervention RCTs should be informed by theory, which should 
include the important mediating variables that are hypothesised to change with 
treatment and in turn have an effect on outcome/s. It is interesting to note that 
four out of nine papers assessed the mediating role of anxiety/psychological 
distress, without an inclusion of a cognitive measure. This is despite the fact that 
the majority of studies referenced a cognitive behavioural model as a basis for 
informing intervention design.  
 
Gastrointestinal Specific Anxiety Versus General Anxiety  
All studies except one (Hunt et al., 2009) measuring GSA utilised the VSI (Labus 
et al., 2004). The VSI incorporates items that pertain to feelings of anxiety 
specifically relating to IBS symptoms, as well as IBS specific cognitions and 
behaviours. The other measure of GSA was not a validated measure. The authors 
used items from a general anxiety scale that had been tailored to apply to specific 
IBS related symptoms (Hazlett-Stevens et al., 2003). There may be an argument 
for the development of a scale that specifically measures GSA, without the 
inclusion of cognitive and behavioural items. Such a measure may allow the 
33 
 
elucidation of the relationship between illness specific cognitions, behaviours 
and GSA. 
 
The review suggests that psychological treatments achieve improved outcomes,  
predominantly by reducing GSA, rather than general anxiety.  Analysis conducted 
by Garland et al (Garland et al., 2012) compared a series of path models to assess 
how well they fit the data. The model including a general measure of 
psychological distress was found not to fit the data as well as the final model, 
which included GSA amongst other variables described earlier. It must however, 
be acknowledged that there is a high co-morbidity of anxiety in IBS populations 
(Fond et al., 2014). Consequently, it is likely that psychological approaches 
targeting general anxiety, may also achieve a reduction in symptom severity. The 
distinction, between general and GSA is important particularly for treatments 
provided to individuals with IBS who don’t have high general anxiety.   
 
An Assimilated Model of Mediation 
A model of mediation for psychological treatment effect is proposed based on the 
findings of the review (figure 4). The review finds that both illness specific 
cognitions and GSA are predominant mediators of treatment effect. There is also 
preliminary evidence that illness specific behaviours have a mediating effect. The 
paper assessing the role of illness specific behaviours found that change in 
behaviours preceded change in illness specific cognitions (Reme et al., 2011). 
This may indicate that interventions targeting IBS specific behaviour change, are 
effective because this subsequently results in cognitive change. It must, however 
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be acknowledged, that the study lacked temporal precedence (Reme et al., 2011). 
This limits the extent to which the sequence of causality can be inferred.  
 
The review opens questions regarding the relationship between illness specific 
cognitions, behaviours and GSA. It seems likely that there is a bidirectional 
relationship between symptoms of GSA, cognitions and behaviour. We propose 
that the relationship between these three variables impact on symptom severity 
via the autonomic nervous system and HPA axis. These are systems involved in 
the physiological stress response and key components of the BGA (figure 4) 
(Kennedy et al., 2014, Kennedy et al., 2012). This makes intuitive sense as the 
GSA is likely to be predictive of and predicted by autonomic arousal (Mayer and 
Tillisch, 2011). 
 
This review does not support the hypothesis that psychological treatments are 
effective in reducing symptom severity by targeting co-morbid anxiety. The 
implications for psychological treatments delivered for IBS, would be that target 
for change should be illness specific factors (GSA, cognitions, behaviours) rather 
than general levels of anxiety.   
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Less Commonly Measured Mediators 
 
Interestingly two studies investigated the potential mediating role of QoL on 
treatment outcome (Labus et al., 2013, Lackner et al., 2007). One assessed 
whether the impact of treatment on QoL produced a reduction in symptom 
severity and the other assessed whether QoL had a mediating role in a path 
leading from treatment  symptom severity  QoL  distress, including a 
feedback loop to QoL. The hypothesized mediating role between the studies was 
therefore rather different. In neither study was a rationale for the investigation 
of QoL as a mediator presented, although both studies found significant 
mediation. Intuitively QoL is generally regarded as an outcome measure rather 
than a mediator measure.  
 
Variables that were not found to mediate the effect of treatment on symptom 
severity were depression (Jones et al., 2011) and perceived stress (Ljótsson et 
al., 2013). Such results provide a greater understanding of how to focus 
treatment, suggesting that depression and stress do not necessarily need to be 
targeted in order to achieve improve outcomes.  Further studies assessing these 
variables as mediators would be required before definitively drawing this 
conclusion. 
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Limitations  
The review is limited by the small number of meditational studies that have been 
conducted to date. Perhaps also due to the empirically based nature of CBT, the 
majority of the psychological interventions included in review were CBT or 
designed in accordance with a CBT model. The review was therefore not able to 
explore mechanisms that may be responsible for change in different therapeutic 
approaches. Furthermore, potential similarities between different treatment 
approaches cannot be considered.  
 
Another limitation of the literature reviewed was that the degree of mediation 
effect could not be uniformly compared across studies. Some papers did not 
report effect sizes for the mediator variables or paths at all, whilst others 
presented effect sizes for mediating paths rather than individual variables. The 
review examines objectively whether mediation was found by considering the 
significance, confidence intervals and effect sizes available of the indirect effects 
and path models tested. It does not examine the nuances of individual analyses 
contained in the discussion of included papers.  
 
Recommendations for Future Mediation Studies 
The review highlights the importance of theoretically informed design of 
mediation studies. Future studies conducting mediation in the context of a 
psychological intervention should carefully consider what the targets of change 
are as informed by the prescribed model of treatment. Measurements of these 
targets for change in the form of validated and reliable questionnaires should be 
included in mediation models. This would allow more complete mediation 
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analysis that can accurately assess how well such models fit the data. In the 
context of mediation studies within psychological treatments for IBS, this would 
mean that researchers include measurements of anxiety/distress, cognitions and 
behaviours.  
Based on the results of this review, it would appear important for researchers to 
further elucidate the relationship between cognitive change and change in 
anxiety, or more specifically, gastrointestinal anxiety. It may be useful to 
understand whether change in one is dependent on change in the other, or 
whether change is co-occurring. In addition, few researchers have investigated 
the potential mediating role of illness-related behaviours. Future studies 
assessing mediation in this area, should include a behavioural measure to further 
understand whether this is an important mechanism for change.  
Conclusion 
There is a clear indication that cognitive change is important for reducing 
symptom severity as well as enhancing quality of life in IBS. From the minimal 
investigation into the mechanistic role of behaviour, it seems that the reduction 
of certain toileting and avoidance behaviour may also be important for 
improving these outcomes in IBS. Different studies utilized different measures of 
distress/anxiety with equivocal findings regarding their mechanistic role in 
psychosocial interventions on outcome. This was further complicated by the use 
of the VSI, which appears to be a compound measure.  
 
Future mediation studies and models need to include all mediating variables 
implicated by the theoretical model of treatment. The limited number of studies 
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to date suggests that it is premature to draw conclusions about the need for the 
modification of treatment practices. However, the review does provide 
substantial support for the targeting of unhelpful cognitions as a mechanistic 
process involved in improving outcomes in IBS.  
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Table 1: Study characteristics  
Study Study 
Design 
Sample 
Size 
Sample 
(age, 
gender, 
diagnostic 
criteria) 
Control 
Group 
Theore
tical 
Model 
Intervention (duration, amount, time period) Intervention 
delivery (by 
nurse, 
therapist) 
Adherenc
e to 
interventi
on  
 
Time points of 
assessment in 
mediation 
analysis 
Garland et 
al 2008 
RCT 75  
 
100% 
female 
Mean age 
42 
ROME II 
criteria  
Receiving 
TAU 
Support 
group with 
psycho-
education 
MBSR  8 weekly 2-hour group sessions and 1 half day retreat.  
MBSR programme with adaptation for IBS in terms of 
focal points of meditation & homework including 
psycho-education on IBS 
Certified 
health coach 
with 10 years’ 
experience in 
teaching 
MBSR in 
clinical 
settings 
NR Baseline* 
Two weeks post 
treatment* 
3 months 
Reme et al 
2011 
RCT 149 82% 
female 
Mean age 
33 
GP 
diagnosed 
IBS 
Mebeverine 
alone 
CBT  6 weekly 50-min sessions face-to-face. CBT based on 
Lang’s three systems model and adapted to IBS in terms 
of cognitions and behaviours focused upon. 270mg 
Mebeverine taken 3 times daily in addition 
Four general 
practice nurses 
trained to 
deliver CBT 
59% 
received 
interventi
on 
 
Baseline * 
First follow up at 
1.5 months* 
3 months 
6 months 
12 months 
42 
 
 
 
 
Receiving 
Mebeverin
e 
 
Labus et 
al (2012) 
RCT 69 
 
72.5% 
female 
Mean age 
46 
ROME II  
 
WL Control  CBT  5 weekly 2-hour group sessions. Intervention consisted 
of  (1) education on neurobiology of stress and IBS in 
the context of the three systems CBT model (2) 
psychological focus of role of cognitions and behaviours 
(3) relaxation training (4) homework including symptom 
diaries and relaxation training 
Lead by a 
gastroenterolo
gist (45% of 
sessions) and a 
therapist (55% 
of sessions).  
NR Baseline* 
Post treatment (5 
weeks)* 
3 months* 
TAU= Treatment as usual, NR= Not reported, * = time point assessment included in mediation analysis 
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Table 1 Continued: Study characteristics 
Study Study 
Design 
Sample 
Size 
Sample 
(age, 
gender, 
diagnostic 
criteria) 
Control 
Group 
Theore
tical 
Model 
Intervention (duration, amount, time period) Intervention 
delivery (by 
nurse, 
therapist) 
Adherenc
e to 
interventi
on  
 
Time points of 
assessment in 
mediation 
analysis 
Chilcot & 
Moss-
Morris 
(2013) 
RCT 64  
 
73% 
female 
Mean age 
39 
ROME I 
modified 
or ROME 
II 
receiving 
TAU 
TAU 
receiving an 
IBS fact 
sheet on how 
IBS 
diagnosed 
CBT  1 one-hour face to face session with a health 
psychologist and a comprehensive CBT based self-
management manual divided into 7 chapters to be 
completed over 7-8 week period in addition to IBS fact 
sheet.  
Self-
management 
intervention 
with 1 session 
with health 
psychologist 
93.5% 
received 
interventio
n 
Baseline* 
Post treatment (2 
months)* 
5 months 
8 months* 
Jones et al 
(2011) 
RCT 105  
 
81% 
female 
Mean age 
42 
ROME I  
(1) 
Relaxation 
therapy. (2) 
TAU  
CBT 8 weekly 1-hour face-to-face CBT sessions. Intervention 
consisted of a manual-based programme incorporating 
realistic symptom appraisal, enhanced coping strategies, 
cognitive restructuring and problem solving. PTs also 
received TAU and relaxation training.  
Clinical 
psychologist  
NR Baseline* 
Midpoint (4 
weeks)* 
Post treatment (8 
weeks)*  
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6 months  
1 year.   
Hunt et al 
(2009) 
RCT 54  
 
81.5% 
female 
Mean age 
38 
Self report 
of medical 
IBS 
diagnosis  
WL control CBT 5 weekly web delivered modules with homework 
assignments submitted by email. Individualised feedback 
given within 48 hours. Modules included (1) psycho-
education on biological link between stress and GI 
symptoms & relaxation training (2) cognitive stress 
management (3) catastrophic thinking (4) graduated 
exposure (5) behavioural experiments  
Self-
management 
intervention  
62% 
received 
active 
treatment 
and 
completed 
6 week 
assessmen
t  
Baseline* 
Post treatment (6 
weeks)* 
3 months (for 
intervention group 
only)* 
TAU= Treatment as usual, NR= Not reported, * = time point assessment included in mediation analysis 
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Table 1 Continued: Study characteristics 
Study Study 
Design 
Sample 
Size 
Sample 
(age, 
gender, 
diagnostic 
criteria) 
Control 
Group 
Model Intervention (duration, amount, time period) Intervention 
delivery (by 
nurse, 
therapist) 
Adhere
nce to 
interven
tion  
 
Time points of 
assessment in 
mediation 
analysis 
Lackner et 
al (2007) 
RCT 147  
 
147 PTs 
82% 
female 
Mean age 
48 
Rome II 
diagnosis 
Psycho-
educational 
support. 
WL Control 
CBT 10 weekly 90-minute group CBT sessions.  Intervention 
consisted of a manual-based programme incorporating 
contextual/situational factors associated with flare-ups, 
unhelpful cognitions, enhancing coping strategies and 
problem solving abilities. 
Three clinical 
psychologists 
with average of 
10 years 
experience 
delivering 
psychological 
treatments to 
painful medical 
disorders. 
90.8% 
complete
d active 
treatmen
t 
Baseline * 
Post treatment (12 
weeks)* 
Ljotsson et 
al (2013) 
RCT 195 
 
79% 
female 
Mean age 
38 
ROME III 
Internet-
delivered 
stress 
management 
CBT 10-week internet-delivered CBT. Intervention consisted 
of exposure & mindfulness exercises including (1) 
exposure to symptoms by engaging in behaviours 
believed to trigger symptoms (2) reduction of safety 
behaviours (3) exposure to behaviours normally avoided 
Therapist/clinic
al psychologist/ 
psychology 
graduate student 
NR Weekly from 
week 1 – 10*  
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diagnosis when experiencing symptoms (4) altering of toileting 
habits (5) a range of mindfulness exercises to practice 
daily. Participants also received regular online support.   
Wolitzky 
et al (2012 
RCT 76  
 
74% 
female 
Mean age 
39 
ROME II 
diagnosis 
Attentional 
Control or 
stress 
management 
CBT 10 weekly 50-minute sessions. CBT –introceptive 
exposure intervention based on CBT for panic disorder 
and adapted for the IBS population. Intervention 
consisted of (1) psycho-education of brain-gut 
physiological relationship (2) attentional control skills 
(3) cognitive reframing of specific illness cognitions (4) 
interoceptive exposure to IBS relevant visceral 
sensations (5) exposure to behaviours normally avoided 
when experiencing symptoms 
NR NR Baseline* 
Mid-treatment 
(week 5)* 
Post treatment 
(week 10)* 
Follow up (5 
months) 
 
TAU= Treatment as usual, NR= Not reported, * = time point assessment included in mediation analysis 
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Table 2: Results 
Study Outcome 
Variable/s 
Main 
effect 
analysis 
Mediator 
variables  
Effect of 
intervention 
on mediators 
Mediation 
analysis 
Indirect effects tested Results: Mediating effects on 
symptom severity (SS) 
Results: Mediating 
effects on QoL 
Garlan
d et al 
2008 
 IBS 
Symptom 
Severity 
(IBS-SSS) 
 
 IBS-Related 
Quality of 
Life (IBS-
QoL) 
RM-
ANOVA 
Nonreactivity 
(FFMQ subscale) 
Pain 
Catastrophizing 
(CSQ pain 
catastrohpizing 
subscale) 
Visceral 
Sensitivity (VSI) 
Reinterpretation 
of Pain Sensations 
(CSQ 
reinterpreting pain 
Significant 
improvement 
in non-
reactivity, 
pain 
catastrophizin
g, VSI, 
cognitive 
reinterpretatio
n of pain and 
psychological 
distress.  
Path 
Analysis 
5 models mediation 
models (one full and four 
partial)  
 
Significant model of full mediation: 
 
T increased reinterpretation of 
pain and nonreactivity  decreased 
pain catastrophizing and visceral 
sensitivity  (and increased 
reinterpretation of pain  reduced 
SS.  
 
 
 
 
Tdecreased visceral 
sensitivity and pain 
catastrophizing  
increased QoL  
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ASI= Anxiety Sensitivity Index (Peterson and Heilbronner, 1987) B-IPQ = Brief Illness Perception Questionnaire (Broadbent et al., 2006) BRQ = Behavioural Responses Questionnaires (Reme et al., 2010) BSSS = 
Bowel Symptom Severity Scale (Boyce et al., 2000) CBSQ = Cognitive and Behavioural Responses to Symptoms Questionnaire (Moss-Morris and Skerrett, 2006) CSQ = Coping Strategies Questionnaire (Rosenstiel 
and Keefe, 1983) FBD =  Cognitive Scale for Functional Bowel Disorders (Toner et al., 1998) FFMQ = Five Facet Mindfulness Questionnaire (Baer et al., 2006) GSRS-IBS = Gastrointestinal Symptom Rating Scale 
(Svedlund et al., 1988) Global GI SS = Global Gastrointestinal symptom severity, an analogue scale from 0-20 (Labus et al., 2013) GSIBSI = Global Severity Index of Brief Symptom Inventory (Derogatis and 
subscale) 
Psychological 
Distress (BSI) 
Reme 
et al 
2011 
 IBS 
Symptom 
Severity 
(IBS-SSS) 
 
 Work and 
Social 
Adjustment 
Scale 
(WSAS) 
 
 Anxiety 
(HADs) 
Regression  Behaviour 
Responses 
Questionnaire 
(BRQ) 
Cognitive Scale 
for Functional 
Bowel Disorders 
(FBD) 
Significant 
improvement 
in behavioural 
scores in CBT 
group 
Significant 
improvement 
in cognitive 
scores in CBT 
group – but 
not after 3 
month follow 
up 
Path 
Analysis 
Compared 2 path models 
of mediation for full and 
partial mediation: (1) T 
 behaviour  
cognitions  outcome 
 
(2) T  cognitions  
behaviour  outcome 
for each outcome.  
 
Partial mediation 
T behaviour  cognition  SS 
with direct path from behaviour 
SS 
 
 
Partial mediation 
Tbehaviour  cognition 
 WSAS with direct path 
from behaviour WSAS 
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Spencer, 1993) HADS = Hospital Anxiety and Depression Scale (Zigmond and Snaith, 1983) IBS-QoLa = IBS Quality of Life (Patrick et al., 1997) IBS-QoL b = IBS related Quality of Life (Drossman et al., 2000) 
IBS-SS = IBS Symptom Severity Score (Francis et al., 1997) WSAS = Work and Social Adjustment Scale (Mundt et al., 2002) VSI = Visceral Sensitivity Index (Labus et al., 2004) VAS= Visceral Anxiety Sensitivity, 
5 items developed to assess gastrointestinal specific anxiety (Hazlett-Stevens et al., 2003) 
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Table 2: Results Tables Continued  
Study Outcome 
Variable/s 
Main 
effect 
analysis 
Mediator 
variables  
Effect of 
intervention on 
mediators 
Mediation 
analysis 
Indirect effects 
tested 
Results: Mediating effects on 
symptom severity (SS) 
Results: Mediating 
effects on QoL 
Labus 
et al 
(2012) 
Symptom 
Severity 
(Global GI 
symptom 
severity) 
 
Repeated 
measures 
GLM 
IBS-QoLb 
depression 
(HADs) 
anxiety (HADs)  
Visceral 
Sensitivity (VSI) 
Catastrophizing 
(subscale of CSQ) 
Significant positive 
change at 5 week, 
and 3 month follow 
up of: 
 IBS-QoL  
 depression  
 catastrophizing 
 
Significant 
reduction of VSI at 
5 weeks 
Path 
Analysis  
Moderated 
mediation model: 
Baseline QoL = 
moderator entered 
into mediation 
model with IBS-
QoL, HADs, VSI, 
Catastrophizing 
entered as M 
variables and GI 
Severity as outcome  
T  IBS-QoL  SS when baseline 
IBS-QoL was low.   
 
 
T  Anxiety  SS when baseline 
IBS-QoL was low.   
 
N/A 
Chilcot 
& 
Moss-
Morris 
(2013) 
 IBS-SS 
 WSAS 
 HADS 
ANCOVA Brief Illness 
Perception 
Questionnaire (B-
IPQ) 
Cognitive and 
Significant 
decrease in 
catastrophizing, 
damaging beliefs, 
and fear avoidance 
Path 
Analysis 
Separate path 
models conducted 
for each significant 
mediator to explore 
the relationship of 
Partial mediation  
T  Illness Perception  IBS-SSS 
with direct effect of TSS 
 
Partial mediation  
T  Illness 
PerceptionsWSAS 
with direct effect of 
TWSAS 
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ASI= Anxiety Sensitivity Index (Peterson and Heilbronner, 1987) B-IPQ = Brief Illness Perception Questionnaire (Broadbent et al., 2006) BRQ = Behavioural Responses Questionnaires (Reme et al., 2010) BSSS = 
Bowel Symptom Severity Scale (Boyce et al., 2000) CBSQ = Cognitive and Behavioural Responses to Symptoms Questionnaire (Moss-Morris and Skerrett, 2006) CSQ = Coping Strategies Questionnaire (Rosenstiel 
and Keefe, 1983) FBD =  Cognitive Scale for Functional Bowel Disorders (Toner et al., 1998) FFMQ = Five Facet Mindfulness Questionnaire (Baer et al., 2006) GSRS-IBS = Gastrointestinal Symptom Rating Scale 
(Svedlund et al., 1988) Global GI SS = Global Gastrointestinal symptom severity, an analogue scale from 0-20 (Labus et al., 2013) GSIBSI = Global Severity Index of Brief Symptom Inventory (Derogatis and 
Spencer, 1993) HADS = Hospital Anxiety and Depression Scale (Zigmond and Snaith, 1983) IBS-QoLa = IBS Quality of Life (Patrick et al., 1997) IBS-QoL b = IBS related Quality of Life (Drossman et al., 2000) 
IBS-SS = IBS Symptom Severity Score (Francis et al., 1997) WSAS = Work and Social Adjustment Scale (Mundt et al., 2002) VSI = Visceral Sensitivity Index (Labus et al., 2004) VAS= Visceral Anxiety Sensitivity, 
5 items developed to assess gastrointestinal specific anxiety (Hazlett-Stevens et al., 2003) 
 
 
Behavioural 
Responses to 
Symptoms 
Questionnaire 
(CBSQ) 
Causal symptom 
attribution 
HADS 
subscales 
(cognitions) of the 
CBSQ. Significant 
change in symptom 
attribution and 
illness perceptions.  
T M  Outcome 
(for each outcome) 
 
 
T Damaging beliefs  
WSAS 
with direct effect of 
TWSAS 
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Table 2: Results Tables Continued  
Study Outcome 
Variable/s 
Main 
effect 
analysis 
Mediator 
variables  
Effect of 
intervention 
on mediators 
Mediation 
analysis 
Indirect effects tested Results: Mediating effects on 
symptom severity (SS) 
Results: Mediating 
effects on QoL 
Jones 
et al 
(2011) 
IBS 
Symptom 
Severity 
(BSSS) 
 
RM- 
ANOVA 
Anxiety (HADS) 
Depression 
(HADS)  
Significant 
change in 
anxiety from 
baseline to 
midpoint but 
reversed from 
midpoint to 
end point.  
Path 
analysis 
Path model from TSS 
with inclusion of 
different specified paths 
involving anxiety and 
depression.  
Model not an adequate fit according 
to Chi2 goodness of fit  (X2 =285.9, 
29 df, P<.0005) 
 
Did not report findings for indirect 
paths.  
N/A 
Hunt et 
al 
(2009) 
 IBS 
Symptom 
Severity 
(GSRS-
IBS) 
 IBS- QoL 
ANCOVA Anxiety (ASI) 
GI specific 
anxiety (VAS) 
General 
catastrophizing 
(subscale CSQ) 
GI specific 
catastrophizing 
Significant 
change in all 
outcome and 
mediating 
variables post 
treatment  
ANCOVA 
utilising 
Baron & 
Kenny’s 
framework 
All mediator variables 
tested for indirect effects 
on symptom severity and 
IBS-QoL.  
General catastrophizing found to 
mediate effect of treatment on 
symptom severity. 
 
No other mediation found.  
N/A 
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(subscale CSQ) 
Lackne
r et al 
(2007) 
 IBS 
Symptom 
Severity 
(Visual 
Analogue 
Scale) 
 IBS QoL 
 
Two way 
ANOVA 
Psychological 
distress (BSI)  
IBS QoLa 
Psychological 
distress 
reduced 
(significance 
not reported) 
IBS QoL 
increased 
(significance 
not reported) 
Path 
Analysis 
Path model from TSS, 
QoL, distress, with 
bidirectional paths 
between all three 
variables to each other.  
Model fit not reported.  
 
No significant mediation effect on 
symptom severity reported 
 
 
Model fit not reported 
 
TSS  IBS QoL 
 
 
ASI= Anxiety Sensitivity Index (Peterson and Heilbronner, 1987) B-IPQ = Brief Illness Perception Questionnaire (Broadbent et al., 2006) BRQ = Behavioural Responses Questionnaires (Reme et al., 2010) BSSS = Bowel Symptom 
Severity Scale (Boyce et al., 2000) CBSQ = Cognitive and Behavioural Responses to Symptoms Questionnaire (Moss-Morris and Skerrett, 2006) CSQ = Coping Strategies Questionnaire (Rosenstiel and Keefe, 1983) FBD =  Cognitive 
Scale for Functional Bowel Disorders (Toner et al., 1998) FFMQ = Five Facet Mindfulness Questionnaire (Baer et al., 2006) GSRS-IBS = Gastrointestinal Symptom Rating Scale (Svedlund et al., 1988) Global GI SS = Global 
Gastrointestinal symptom severity, an anolgue scale from 0-20 (Labus et al., 2013) GSIBSI = Global Severity Index of Brief Symptom Inventory (Derogatis and Spencer, 1993) HADS = Hospital Anxiety and Depression Scale 
(Zigmond and Snaith, 1983) IBS-QoLa = IBS Quality of Life (Patrick et al., 1997) IBS-QoL b = IBS related Quality of Life (Drossman et al., 2000) IBS-SS = IBS Symptom Severity Score (Francis et al., 1997) WSAS = Work and 
Social Adjustment Scale (Mundt et al., 2002) VSI = Visceral Sensitivity Index (Labus et al., 2004) VAS= Visceral Anxiety Sensitivity, 5 items developed to assess gastrointestinal specific anxiety (Hazlett-Stevens et al., 2003) 
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Table 2: Results Tables Continued  
Study Outcome 
Variable/s 
Main 
effect 
analysis 
Mediator 
variables  
Effect of 
intervention 
on mediators 
Mediation 
analysis 
Indirect effects tested Results: Mediating effects on 
symptom severity (SS) 
Results: Mediating 
effects on QoL 
Ljotsso
n et al 
(2013) 
IBS 
Symptom 
Severity 
(GSRS-IBS) 
Parallel 
process 
latent 
growth 
curve 
model 
Gastrointestinal 
symptom specific 
anxiety (VSI) 
Stress (PSS) 
Significant 
differences in 
linear growth 
rate of 
VSI 
 
Stress 
significantly 
decreased over 
time – no 
difference 
between 
groups 
 
Parallel 
process 
latent 
growth 
curve 
model 
Two separate parallel 
bivariate growth models 
conducted: 
T VSI  GSRS-IBS 
 
TPSS GSRS-IBS 
VSI found to significantly mediate 
the effect of treatment on GSRS.  
 
PSS did not significantly mediate 
the effect of treatment on GSRS 
 
N/A 
Wolitz
ky et al 
IBS 
symptom 
Hierarchic
al linear 
Gastrointestinal 
symptom specific 
Significantly 
reduced GSA.  
Hierarchic
al Linear 
Group x VSI slope 
interaction 
 VSI mediated treatment effect on 
outcome but not differentially 
N/A 
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(2012) severity (a 
composite 
bowel 
symptom 
severity 
index, 
BSSS)  
 IBS-QoL 
model anxiety (VSI) 
 
Model across treatment and control groups.   
ASI= Anxiety Sensitivity Index (Peterson and Heilbronner, 1987) B-IPQ = Brief Illness Perception Questionnaire (Broadbent et al., 2006) BRQ = Behavioural Responses Questionnaires (Reme et al., 2010) BSSS = Bowel Symptom 
Severity Scale (Boyce et al., 2000) CBSQ = Cognitive and Behavioural Responses to Symptoms Questionnaire (Moss-Morris and Skerrett, 2006) CSQ = Coping Strategies Questionnaire (Rosenstiel and Keefe, 1983) FBD =  
Cognitive Scale for Functional Bowel Disorders (Toner et al., 1998) FFMQ = Five Facet Mindfulness Questionnaire (Baer et al., 2006) GSRS-IBS = Gastrointestinal Symptom Rating Scale (Svedlund et al., 1988) Global GI SS = 
Global Gastrointestinal symptom severity, an analogue scale from 0-20 (Labus et al., 2013) GSIBSI = Global Severity Index of Brief Symptom Inventory (Derogatis and Spencer, 1993) HADS = Hospital Anxiety and Depression 
Scale (Zigmond and Snaith, 1983) IBS-QoLa = IBS Quality of Life (Patrick et al., 1997) IBS-QoL b = IBS related Quality of Life (Drossman et al., 2000) IBS-SS = IBS Symptom Severity Score (Francis et al., 1997) WSAS = Work 
and Social Adjustment Scale (Mundt et al., 2002) VSI = Visceral Sensitivity Index (Labus et al., 2004) VAS= Visceral Anxiety Sensitivity, 5 items developed to assess gastrointestinal specific anxiety (Hazlett-Stevens et al., 2003) 
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Table 3: Treatment models and intervention protocols used.  
Study Treatment Model 
Explicitly Referenced 
Intervention Protocol Components 
Garland et al  
(2008) 
Mindfulness Based 
Stress Reduction tailored 
to IBS symptoms 
(Gaylord et al., 2009) 
 
(1) Sitting, walking, yoga and body scan mediations. (2) Mindfulness tailored towards IBS by emphasizing relevance of mindfulness in 
coping with IBS-related symptoms and perceptions. (3) Psychoeducation component was included regarding the physiological relationship 
between stress and symptoms (4) Promotion of  awareness of sensory versus emotional processing of interoceptive signals, with view to 
counteract catastrophizing.  
Reme et al 
(2011) 
CBT Three systems 
model (Kennedy et al., 
2006a) 
 
 
(1) Assessment of main symptom, precipitating factors, maintaining cognitions & behaviours, discussion of treatment rationale (2) 
Monitoring symptoms, behaviours & cognitions and interrelations (3) Long term & short term behavioural goal setting with relation to 
symptoms- graded exposure (4) Behavioural experiments to test beliefs about consequences of IBS  (5) Psychoeducation about stress and 
bowel symptoms (6) Problem solving and symptom & stress management techniques (7) Managing flare ups 
Labus et al 
(2012) 
Biopsychosocial model 
of IBS 
(1) Psychoeducation about stress, IBS self management regarding diet and medication (2) Psychoeducation regarding role of symptom 
appraisal, beliefs and attitudes and links between cognitions, mood, stress, behavioural responses and symptoms (3) Alternative responses 
(4) Relaxation exercises (5) Monitoring symptoms, behaviours & cognitions and interrelations 
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Chilcot & 
Moss-Morris 
(2013) 
CBT (Moss-Morris et 
al., 2010) 
Treatment rationale explained (2) Monitoring symptoms, behaviours & cognitions and interrelations (3) General consideration of unhelpful 
cognitions, perfectionism and patterns of boom/bust (4) Long term & short term behavioural goal setting with relation to symptoms- 
graduated exposure (5) Psychoeducation about stress and bowel symptoms, sleep hygiene (6) Problem solving and symptom & stress 
management techniques including relaxation techniques (7) Managing flare ups 
 
 
Jones et al 
(2011) 
CBT/Biopsychosocial 
model (Jones et al., 
2011) 
 
(1) Realistic symptom appraisal (2) Enhanced coping strategies (3) Cognitive restructuring (4) Problem solving 
Hunt et al 
(2009) 
CBT with inclusion of 
module targeting IBS 
specific catastrophizing 
(Hunt et al., 2009) 
 
(1) Psychoeducation about stress and bowel symptoms  (2) Relaxation training (3) Monitoring cognitions & emotions (4) IBS specific 
catastrophizing, thought records & identification of interrelationship between IBS-specific cognitions, behaviours, emotions and symptoms  
(5) Graduated exposure (6) Behavioural experiments to test beliefs about social consequences of IBS  
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Lackner et al 
(2007) 
CBT (Blanchard et al., 
2007) 
(1) Psychoeducation about stress and bowel symptoms (2) Monitoring symptoms, behaviours & cognitions and interrelations (3) Problem 
solving and symptom & stress management techniques (4) Relaxation training (5) cognitive restructuring for modifying faulty threat 
appraisals that underlie physiologic and emotional reactivity 
Ljotsson et al 
(2013) 
Exposure Based 
Cognitive Behavioural 
Therapy (Ljótsson et al., 
2011) 
 
(1) Mindfulness exercises to promote awareness of interrelationship between GI symptoms, cognitions, emptions, behaviours/behavioural 
impulses (2) Exposure exercises & behavioural experiments 
Wolitzky et al 
(2012) 
Adapted protocol of 
CBT for panic disorder 
(DeCola, 2001, Craske 
and Barlow, 2006)   
(1) Cognitive restructuring of IBS specific beliefs (2) Exposure exercises & behavioural experiments (3) Attentional control skills to reduce 
symptom focussing 
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